A Randomized, Double Blind, Placebo-controlled Phase II Study of KPS-0373 in Patients With SCD
A Randomized, Double Blind, Placebo-controlled Phase II Study of KPS-0373 in Patients With SCD
The purpose of this study is to evaluate the efficacy and safety of KPS-0373 compared to placebo in patients with Spinocerebellar Degeneration (SCD).
Inclusion Criteria:
Exclusion Criteria:
Tokyo and Other Japanese City, Japan